LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

NCT00906048 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped lack of recruitment

Conditions

Infection

Interventions

DRUG: Levofloxacin (HR355) and Rifampicin Therapy

Sponsor

Sanofi